ECSP21082738A - Microvesículas terapéuticas de bacterias probióticas - Google Patents

Microvesículas terapéuticas de bacterias probióticas

Info

Publication number
ECSP21082738A
ECSP21082738A ECSENADI202182738A ECDI202182738A ECSP21082738A EC SP21082738 A ECSP21082738 A EC SP21082738A EC SENADI202182738 A ECSENADI202182738 A EC SENADI202182738A EC DI202182738 A ECDI202182738 A EC DI202182738A EC SP21082738 A ECSP21082738 A EC SP21082738A
Authority
EC
Ecuador
Prior art keywords
therapeutic microvesicles
probiotic bacteria
bacteria
microvesicles
therapeutic
Prior art date
Application number
ECSENADI202182738A
Other languages
English (en)
Inventor
Wolfgang Kunze
John Bienenstock
Stefan Roos
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of ECSP21082738A publication Critical patent/ECSP21082738A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe un método para proporcionar microvesículas terapéuticas de bacterias probióticas que comprende exponer las bacterias a un tratamiento inductor durante el cultivo para inducir la producción de microvesículas terapéuticas por parte de las bacterias. Las microvesículas terapéuticas se pueden utilizar en el tratamiento contra, por ejemplo, cólicos, un trastorno o enfermedad gastrointestinal infantil, un trastorno de dolor gastrointestinal, una enfermedad de pérdida ósea y/o una enfermedad periodontal.
ECSENADI202182738A 2019-04-17 2021-11-17 Microvesículas terapéuticas de bacterias probióticas ECSP21082738A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1950483 2019-04-17
SE1951222 2019-10-25

Publications (1)

Publication Number Publication Date
ECSP21082738A true ECSP21082738A (es) 2022-01-31

Family

ID=70476308

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202182738A ECSP21082738A (es) 2019-04-17 2021-11-17 Microvesículas terapéuticas de bacterias probióticas

Country Status (19)

Country Link
US (2) US11857582B2 (es)
EP (2) EP3773648B1 (es)
JP (1) JP7556881B2 (es)
KR (1) KR102855825B1 (es)
CN (1) CN113747908B (es)
AU (1) AU2020258788B2 (es)
BR (1) BR112021019663A2 (es)
CL (1) CL2021002527A1 (es)
EC (1) ECSP21082738A (es)
ES (1) ES2986604T3 (es)
HU (1) HUE067741T2 (es)
IL (1) IL287226B2 (es)
MX (1) MX2021012631A (es)
MY (1) MY204586A (es)
PH (1) PH12021552578A1 (es)
PL (1) PL3773648T3 (es)
SG (1) SG11202110355RA (es)
WO (1) WO2020214083A1 (es)
ZA (1) ZA202106518B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202110355RA (en) 2019-04-17 2021-11-29 Biogaia Ab Therapeutic microvesicles of probiotic bacteria
WO2022139530A1 (ko) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물
CN113122478B (zh) * 2021-04-26 2022-09-06 江南大学 一株能够缓解辣椒素致胃肠损伤的副干酪乳杆菌及其用途
KR102850200B1 (ko) * 2021-06-18 2025-08-27 경북대학교 산학협력단 핵산 백신 제조 및 유전자 전달을 위한 세균 유래 세포밖 소포체의 용도
CN114292801A (zh) * 2021-11-22 2022-04-08 龚志术 一种益生菌菌株的驯化方法、益生菌菌株、扶微乳及其制备方法
KR102874901B1 (ko) * 2025-05-12 2025-10-23 주식회사 코씨드바이오팜 수국 유래의 락티플란티바실러스 플란타룸 배양액에서 분리된 엑소좀을 함유하는 화장료 조성물
CN120683017A (zh) * 2025-07-04 2025-09-23 东莞市第八人民医院（东莞市儿童医院） 一种乳酸杆菌来源的胞外囊泡及其在防治坏死性小肠结肠炎的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3716938A1 (de) * 1986-05-23 1987-11-26 Heise Dieter Arzneimittel zur behandlung von koliken im saeuglingsalter
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
WO2011027971A2 (ko) * 2009-09-01 2011-03-10 주식회사이언메딕스 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법
KR101752506B1 (ko) * 2010-07-01 2017-06-30 포항공과대학교 산학협력단 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법
EP2833911A4 (en) * 2012-04-06 2016-07-13 Univ Cornell SUB-VACCINE VACCINATING PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
WO2017018440A1 (ja) * 2015-07-27 2017-02-02 セティ株式会社 乳酸菌組成物、発酵乳及びその製造方法、並びに発酵乳製造キット
KR102394638B1 (ko) * 2015-09-30 2022-05-09 (주)아모레퍼시픽 유산균 유래의 세포외 소낭을 포함하는 탈모 방지 또는 육모 촉진용 조성물
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN110520142A (zh) * 2017-05-05 2019-11-29 雀巢产品有限公司 婴儿腹绞痛的治疗
KR101853603B1 (ko) * 2017-05-18 2018-05-02 주식회사 쎌바이오텍 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물
KR102348048B1 (ko) * 2017-06-29 2022-01-10 (주)아모레퍼시픽 유산균 유래의 세포밖 베지클을 포함하는 항노화용 조성물
CN111148531A (zh) * 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
WO2019172598A1 (ko) * 2018-03-05 2019-09-12 주식회사 엠디헬스케어 락토바실러스 속 세균 유래 나노소포 및 이의 용도
WO2019189408A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物
KR102233530B1 (ko) * 2018-11-22 2021-03-31 (주)프로스테믹스 엑소좀 및 이의 다양한 용도
SG11202110355RA (en) 2019-04-17 2021-11-29 Biogaia Ab Therapeutic microvesicles of probiotic bacteria

Also Published As

Publication number Publication date
CN113747908A (zh) 2021-12-03
AU2020258788A1 (en) 2021-10-28
IL287226A (en) 2021-12-01
BR112021019663A2 (pt) 2021-12-07
KR20220007609A (ko) 2022-01-18
US11857582B2 (en) 2024-01-02
ZA202106518B (en) 2025-01-29
EP4410298A2 (en) 2024-08-07
MY204586A (en) 2024-09-05
EP3773648A1 (en) 2021-02-17
CA3136978A1 (en) 2020-10-22
CL2021002527A1 (es) 2022-04-22
KR102855825B1 (ko) 2025-09-11
ES2986604T3 (es) 2024-11-12
US20240082325A1 (en) 2024-03-14
JP7556881B2 (ja) 2024-09-26
IL287226B2 (en) 2025-09-01
EP4410298A3 (en) 2024-11-13
MX2021012631A (es) 2021-11-12
HUE067741T2 (hu) 2024-11-28
AU2020258788B2 (en) 2024-07-04
WO2020214083A1 (en) 2020-10-22
NZ780609A (en) 2025-03-28
EP3773648C0 (en) 2024-06-19
CN113747908B (zh) 2025-07-18
US20210154245A1 (en) 2021-05-27
SG11202110355RA (en) 2021-11-29
PL3773648T3 (pl) 2024-08-26
IL287226B1 (en) 2025-05-01
JP2022529456A (ja) 2022-06-22
PH12021552578A1 (en) 2022-04-04
EP3773648B1 (en) 2024-06-19

Similar Documents

Publication Publication Date Title
ECSP21082738A (es) Microvesículas terapéuticas de bacterias probióticas
MX2018009539A (es) Uso de comunidades microbianas para la salud humana y animal.
CR20170121A (es) Compuestos de anamorelina y sus usos
CO2017007383A2 (es) Métodos para utilizar oligonucleótidos antisentido para smad7
AR054730A1 (es) Nuevas bacterias lacticas utiles como probioticos
CO2020014673A2 (es) Selección y uso de bacterias que apoyan la melatonina para reducir el cólico del lactante
MX2022003442A (es) Composiciones de trazodona pediatrica y metodo de tratamiento con las mismas.
MX2017017136A (es) Composicion para el tratamiento de la nafld.
Sevbitov et al. Experimental substantiation of the bactericidal effect of sodium hypochlorite on the microflora of a purulent wound with odontogenic phlegmons of the face and neck
EP4173648A4 (en) STERILIZATION DEVICE AND METHOD, ACTIVE OXYGEN SUPPLY DEVICE AND ACTIVE OXYGEN TREATMENT DEVICE
TANVI et al. ASSESSMENT OF FEAR PSYCHOSIS AND PRACTICE MODIFICATION IN DENTAL FRATERNITY TO ϑIGHT AGAINST COVID-19-A SURVEY IN CENTRAL INDIA POPULATION
RU2014107682A (ru) Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
JP1735109S (ja) 医療用電極
JP1735110S (ja) 医療用電極
JP1736001S (ja) 医療用包帯
EA201692163A1 (ru) Лекарственное средство для лечения пациентов с тиннитусом
JP1783702S (ja) スキントリートメント用先端器具
JP1785122S (ja) スキントリートメント用先端器具
RU2014124801A (ru) Способ комплексного лечения больных с язвенной болезнью желудка и двенадцатиперстной кишки
RU2009119225A (ru) Способ лечения и профилактики кокцидиозов норок
UA126148U (uk) Спосіб лікування періімплантного мукозиту
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
Barbara Niesel Aromatherapy Use in Patients with Dementia: A Case Study
LV15557A (lv) Metode ūdens dezinfekcijai, izmantojot CaFeO
EA201300166A1 (ru) Способ моделирования экспериментального острого орхиэпидидимита